Arch Therapeutics, Inc. has announced the first shipment of the AC5 Advanced Wound System under a new reimbursement program. AC5 was a synthetic, self-assembling wound care product that enables physicians to provide multimodal support during all stages of the wound healing process.
Convatec Group PLC has entered into an agreement to acquire Triad Life Sciences Inc. that develops innovative bio-based products that meet the needs of surgical and chronic wounds and burns.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4823
Published Date: Apr 14, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Rising incidence of chronic wounds, and growing number of surgeries are the major factors driving the market growth.
The market size of wound care is anticipated to attain a CAGR of 8.40% over the forecast period, i.e., 2023-2035.
The major players in the market are Cardinal Health, B. Braun Melsungen AG, Acelity L.P. Inc., Integra Lifesciences Holdings Corporation, Medtronic plc, and others.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by functions, application, and by region.
The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The product development costs are estimated to be the growth hindering factors for the market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.